View Older Stories View More Recent Stories

Mar 16, 2022 05:58AM Pfizer (PFE) and BioNTech (BNTX) Submit Request for US Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Mar 15, 2022 06:00PM Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Mar 15, 2022 06:00PM Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Feb 11, 2022 01:32PM Pfizer (PFE)/BioNTech (BNTX) Provide Update on Rolling Submission for EAU for COVID-19 Vaccine for Children
Feb 11, 2022 01:30PM Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age
Feb 1, 2022 04:27PM Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA
Feb 1, 2022 04:27PM Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA
Feb 1, 2022 04:20PM Pfizer (PFE) and BioNTech (BNTX) Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4
Feb 1, 2022 04:20PM Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
Jan 25, 2022 06:45AM Pfizer (PFE), BioNTech (BNTX) Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults
Jan 25, 2022 06:45AM Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
Jan 25, 2022 06:45AM Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
Jan 25, 2022 06:45AM  Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
Jan 5, 2022 06:45AM Pfizer (PFE) and BioNTech (BNTX) Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Jan 5, 2022 06:45AM Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Jan 5, 2022 06:45AM Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Jan 5, 2022 06:45AM Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Jan 3, 2022 09:50AM Pfizer (PFE), BioNTech (BNTX) Confirm U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Jan 3, 2022 09:45AM Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Dec 20, 2021 10:05AM Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply
Dec 17, 2021 02:22PM 'Tidal wave': Omicron could put U.S. COVID-19 surge into overdrive
Dec 9, 2021 12:15PM Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Dec 9, 2021 12:15PM Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Dec 9, 2021 12:07PM Pfizer (PFE), BioNTech (BNTX) Confirm U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Dec 9, 2021 12:07PM Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Dec 8, 2021 06:56AM Pfizer and BioNTech Provide Update on Omicron Variant
Dec 8, 2021 06:56AM Pfizer and BioNTech Provide Update on Omicron Variant
Dec 8, 2021 06:55AM Pfizer (PFE) and BioNtech (BNTX) Announces Study Shows Omicron Variant is Neutralized by Their COVID-19 Vaccine With Three Doses
Dec 8, 2021 06:54AM Pfizer and BioNTech Provide Update on Omicron Variant
Dec 7, 2021 04:11PM Studies suggest Pfizer shot may protect only partially against Omicron
Nov 29, 2021 09:30AM Pre-Open Stock Movers 11/29: (KRYS) (ADGI) (TWTR) Higher; (MRK) (UPS) Lower (more...)
Nov 25, 2021 07:30AM Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
Nov 22, 2021 06:46AM Pfizer (PFE), BioNTech (BNTX) Follow-Up Data From Phase 3 Trial of COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Nov 22, 2021 06:46AM BioNTech SE (BNTX) and Pfizer (PFE) Vaccine 100% Effectice Against COVID-19 in 12-15 Age Group per Phase 3 Study
Nov 22, 2021 06:45AM Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Nov 22, 2021 06:45AM Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Nov 22, 2021 06:45AM Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Nov 19, 2021 08:25AM Pfizer (PFE), BioNTech (BNTX) Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 19, 2021 08:25AM Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 19, 2021 08:25AM Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 19, 2021 08:25AM Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 11, 2021 11:00AM Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana
Oct 29, 2021 05:46PM Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children Aged 5-11
Oct 29, 2021 05:45PM Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Oct 29, 2021 05:45PM Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Oct 29, 2021 05:45PM Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Oct 28, 2021 06:58AM Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
Oct 28, 2021 06:58AM Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
Oct 28, 2021 06:45AM US Govt Purchases Additional 50M Doses of Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine
Oct 28, 2021 06:45AM Pfizer and BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
View More Recent Stories View Older Stories